IRadimed Corp (NASDAQ:IRMD)’s share price hit a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $19.25 and last traded at $18.70, with a volume of 446 shares changing hands. The stock had previously closed at $18.60.
IRMD has been the topic of several recent research reports. Zacks Investment Research raised shares of IRadimed from a “hold” rating to a “buy” rating and set a $17.00 price objective on the stock in a research note on Friday, January 26th. ValuEngine raised shares of IRadimed from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Four research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus price target of $18.33.
The company has a market capitalization of $197.68 million, a price-to-earnings ratio of 233.13 and a beta of 1.40.
In other news, insider Louis S. Waldman sold 30,000 shares of the company’s stock in a transaction on Friday, March 16th. The shares were sold at an average price of $13.83, for a total transaction of $414,900.00. Following the transaction, the insider now directly owns 5,221 shares of the company’s stock, valued at approximately $72,206.43. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Louis S. Waldman sold 5,221 shares of the company’s stock in a transaction on Friday, May 4th. The stock was sold at an average price of $18.19, for a total transaction of $94,969.99. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 37,120 shares of company stock worth $543,938. Corporate insiders own 61.20% of the company’s stock.
Large investors have recently bought and sold shares of the company. Macquarie Group Ltd. grew its stake in shares of IRadimed by 643.1% during the 4th quarter. Macquarie Group Ltd. now owns 8,204 shares of the medical equipment provider’s stock worth $124,000 after purchasing an additional 7,100 shares during the period. O Shaughnessy Asset Management LLC acquired a new position in shares of IRadimed during the 1st quarter worth $162,000. Ranger Investment Management L.P. acquired a new position in shares of IRadimed during the 4th quarter worth $238,000. Cadence Capital Management LLC acquired a new position in shares of IRadimed during the 4th quarter worth $320,000. Finally, Deutsche Bank AG grew its stake in shares of IRadimed by 820.3% during the 4th quarter. Deutsche Bank AG now owns 23,100 shares of the medical equipment provider’s stock worth $349,000 after purchasing an additional 20,590 shares during the period. 17.40% of the stock is currently owned by institutional investors and hedge funds.
IRadimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets under the MRidium name; and MRI compatible patient vital signs monitoring system under the IRadimed name.
Receive News & Ratings for IRadimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRadimed and related companies with MarketBeat.com's FREE daily email newsletter.